{"filings":[{"id":127002,"accession_number":"0001213900-25-099959","cik":1876716,"company_name":"ASPAC II Acquisition Corp.","ticker":"ASCBF","form_type":"8-K","filed_at":"2025-10-17T23:59:59+00:00","items":["1.01","5.02","9.01"],"status":"ready","headline":"ASPAC II issues $500K promissory note to sponsor; director Chan resigns","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $500,000 unsecured promissory note to sponsor A SPAC II (Holdings) Corp on October 17, 2025.","Note non-interest bearing, due at business combination; convertible into warrants at $1.00 per warrant.","Proceeds to be used for working capital and company expenses.","Director Ka Wo Chan resigned effective October 17, 2025, with no disagreement with the company or board."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":64069999.99999999,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":143800,"accession_number":"0001213900-25-072069","cik":1876716,"company_name":"ASPAC II Acquisition Corp.","ticker":"ASCBF","form_type":"8-K","filed_at":"2025-08-05T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"SPAC II Acquisition dismisses Marcum Asia, appoints FundCertify as new auditor","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Audit committee approved dismissal of Marcum Asia and engagement of FundCertify on Aug 5, 2025.","No disagreements or reportable events with Marcum Asia during FY2023, FY2024, and through Aug 5, 2025.","Marcum Asia's reports for FY2023 and FY2024 included a going concern explanatory paragraph.","FundCertify will re-audit FY2023 and FY2024 financials and review first three quarters of 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":64069999.99999999,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":143799,"accession_number":"0001213900-25-069981","cik":1876716,"company_name":"ASPAC II Acquisition Corp.","ticker":"ASCBF","form_type":"8-K","filed_at":"2025-07-31T23:59:59+00:00","items":["5.03","5.07","9.01"],"status":"ready","headline":"ASCB shareholders approve 24-month extension and China target amendment; 344K shares redeemed","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Shareholders approved extension of business combination deadline from Aug 5, 2025 to Aug 5, 2027.","Shareholders approved allowing initial business combination with entities having principal operations in China (incl. Hong Kong, Macau).","Fourth Amended and Restated Memorandum and Articles of Association filed with BVI Registrar.","344,384 ordinary shares (approx 6.1% of outstanding) tendered for redemption in connection with the EGM.","All 5,329,581 votes cast (93.7% of outstanding) were FOR both proposals; no abstentions or broker non-votes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":64069999.99999999,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":143798,"accession_number":"0001213900-25-068269","cik":1876716,"company_name":"ASPAC II Acquisition Corp.","ticker":"ASCBF","form_type":"8-K","filed_at":"2025-07-28T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"ASPAC II Acquisition Corp. replaces majority of board and top executives effective July 28, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Four directors (MacLean, Chan, Biniak, Cummins) resigned; replaced by Yip Tsz Yan, Tsang Wing Sze, Luk Sui Cheung Peter, Minjie Mao.","CEO Serena Shie and CFO Claudius Tsang resigned; Yip Tsz Yan appointed CEO, CFO, and Chairman.","Yip, 32, previously at Topaz Family Office; Tsang, 41, independent director with finance/legal experience.","Luk, 70, managing director of Global Stone & Tile; Mao, 42, founder of Shanghai PanAsia Gemini Financial Consulting.","Indemnity agreements entered with new directors and departing CEO Serena Shie on July 28, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":64069999.99999999,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":143797,"accession_number":"0001213900-25-063920","cik":1876716,"company_name":"ASPAC II Acquisition Corp.","ticker":"ASCBF","form_type":"8-K","filed_at":"2025-07-15T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"ASPAC II Acquisition Corp. issues $152K promissory note to sponsor for working capital","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Issued unsecured promissory note for $152,000 to sponsor A SPAC II (Holdings) Corp. on July 14, 2025.","Note is non-interest bearing and payable no later than consummation or termination of initial business combination.","Sponsor may convert principal into private placement warrants at $1.00 per warrant on same terms as public warrants.","Proceeds will fund company expenses and working capital; repayment from funds outside trust account.","Trust waiver included: sponsor has no claim on trust account monies."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":64069999.99999999,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":196881,"accession_number":"0001213900-24-107151","cik":1876716,"company_name":"ASPAC II Acquisition Corp.","ticker":"ASCBF","form_type":"8-K","filed_at":"2024-12-10T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"ASPAC II Acquisition Corp. issues $160K promissory note to sponsor for working capital","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$160,000 unsecured promissory note issued to sponsor A SPAC II (Holdings) Corp.","Note payable upon business combination; convertible into warrants at $1.00 per warrant.","No interest accrues on the note.","Proceeds used for working capital and expenses."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":64069999.99999999,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":213179,"accession_number":"0001213900-24-080036","cik":1876716,"company_name":"ASPAC II Acquisition Corp.","ticker":"ASCBF","form_type":"8-K","filed_at":"2024-09-19T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"ASPAC II receives Nasdaq delisting notice for failing minimum shareholder rule","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq notified on Sep 13, 2024 that ASPAC II did not meet minimum 400 total shareholders requirement (Rule 5450(a)(2)).","Company failed to regain compliance during extension ending Sep 11, 2024.","Deadline to request hearing before Nasdaq Panel is Sep 20, 2024; otherwise trading suspended Sep 24, 2024.","If delisted, securities expected to trade OTC; company intends to relist upon completion of business combination."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":64069999.99999999,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":213178,"accession_number":"0001013762-24-000716","cik":1876716,"company_name":"ASPAC II Acquisition Corp.","ticker":"ASCBF","form_type":"8-K","filed_at":"2024-07-24T23:59:59+00:00","items":["5.03","5.07","9.01"],"status":"ready","headline":"ASCB shareholders approve extension to August 2025; ~1.6M shares redeemed","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Extension Amendment Proposal approved at EGM on July 23, 2024: deadline extended from August 5, 2024 to August 5, 2025.","1,608,417 ordinary shares were tendered for redemption in connection with the EGM.","Vote results: 6,114,387 for, 350,272 against, 0 abstentions, 0 broker non-votes; quorum 88.6% of outstanding shares.","Third Amended and Restated Memorandum and Articles of Association filed with British Virgin Islands Registrar on July 23, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":64069999.99999999,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":213177,"accession_number":"0001213900-24-062772","cik":1876716,"company_name":"ASPAC II Acquisition Corp.","ticker":"ASCBF","form_type":"8-K","filed_at":"2024-07-19T23:59:59+00:00","items":["7.01","8.01"],"status":"ready","headline":"ASPAC II identifies two potential SPAC targets: Vietnam biofuel and Nepal copper mining","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Entered non-binding LOIs with a Vietnam biofuel target and a Nepal copper mining target; no minimum cash condition.","Biofuel target has been EBITDA positive since 2022; Vietnamese govt may mandate ethanol blend expansion up to 400% demand increase.","Mining target is in exploration stage in Baglung District; preliminary porphyry copper findings identified but unconfirmed.","Previous talks with a medical target have ended; special meeting on July 23, 2024 to vote on extension proposal.","No definitive agreement yet; due diligence and negotiation remain; no guarantee of any deal."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":64069999.99999999,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":250574,"accession_number":"0001213900-24-024055","cik":1876716,"company_name":"ASPAC II Acquisition Corp.","ticker":"ASCBF","form_type":"8-K","filed_at":"2024-03-19T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"ASPAC II receives Nasdaq deficiency letter for insufficient public holders","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received Nasdaq letter on March 15, 2024 for failing to maintain minimum 400 public holders (Rule 5450(a)(2)).","Company has 45 days to submit a compliance plan; Nasdaq may grant up to 180-day extension.","Company intends to submit a compliance plan within the specified period."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":64069999.99999999,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":268125,"accession_number":"0001213900-23-095401","cik":1876716,"company_name":"ASPAC II Acquisition Corp.","ticker":"ASCBF","form_type":"8-K","filed_at":"2023-12-13T23:59:59+00:00","items":["3.01","3.02"],"status":"ready","headline":"Nasdaq notifies ASCB of non-compliance with $50M market value rule; Sponsor obtains 68.1% of Class A via exchange","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received Nasdaq notice on Dec 11, 2023 for failing $50M market value of listed securities over 30 consecutive business days.","Has 180 days (until June 10, 2024) to regain compliance by closing at $50M+ for 10 consecutive business days.","Non-compliance may lead to delisting; Company can apply to Nasdaq Capital Market or appeal.","Sponsor exchanged 4.9M Class B shares for 4.9M Class A shares, now holds ~68.1% of outstanding Class A shares.","New Class A shares subject to same restrictions (transfer, redemption waiver, voting on business combination) as original Class B."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":64069999.99999999,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":285364,"accession_number":"0001213900-23-062779","cik":1876716,"company_name":"ASPAC II Acquisition Corp.","ticker":"ASCBF","form_type":"8-K","filed_at":"2023-08-03T23:59:59+00:00","items":["5.03","5.07"],"status":"ready","headline":"ASCB shareholders approve extension to August 5, 2024; 18M shares redeemed","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Extension Amendment Proposal passed with 14,211,081 votes for and 7,884,094 against.","Amended charter filed with BVI Registrar; deadline for initial business combination extended to August 5, 2024.","18,003,605 ordinary shares tendered for redemption at EGM, representing ~71% of outstanding shares.","NTA Requirement Amendment and Founder Share Amendment also approved by shareholders.","Company had 25,300,000 shares outstanding as of record date July 6, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":64069999.99999999,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":285363,"accession_number":"0001213900-23-060129","cik":1876716,"company_name":"ASPAC II Acquisition Corp.","ticker":"ASCBF","form_type":"8-K","filed_at":"2023-07-27T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"A SPAC II identifies Taiwan medtech target for potential business combination","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["Target specializes in microsphere tech for ultrasound contrast agents and drug delivery.","First product has passed review to enter Phase 3 trial application with USFDA.","Special meeting on Aug 1, 2023 to vote on extension and other proposals.","Company in preliminary talks to enter non-binding LOI with Partner.","No guarantee definitive agreement will be reached; due diligence ongoing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":64069999.99999999,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":359213,"accession_number":"0001213900-22-052566","cik":1876716,"company_name":"ASPAC II Acquisition Corp.","ticker":"ASCBF","form_type":"8-K","filed_at":"2022-08-31T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"A SPAC II Acquisition Corp. names Serena Shie CEO; Tsang resigns as CEO, stays CFO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Claudius Tsang resigned as CEO on Aug 29, 2022; not due to any disagreement with the Company.","Serena Shie appointed CEO same date; Tsang remains as Chief Financial Officer.","Shie has served as President, CFO and board member of Model Performance Acquisition Corp. since March 2021.","No family relationships or related party transactions exist between Shie and the Company's directors or officers."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":64069999.99999999,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":378030,"accession_number":"0001104659-22-066245","cik":1876716,"company_name":"ASPAC II Acquisition Corp.","ticker":"ASCBF","form_type":"8-K","filed_at":"2022-05-31T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"A SPAC II Acquisition Corp. allows separate trading of shares, warrants, and rights effective May 31, 2022","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Ordinary shares (ASCB), warrants (ASCBW), and rights (ASCBR) begin separate trading on Nasdaq as of May 31, 2022.","Units not separated continue to trade under symbol ASCBU; components may be recombined into units.","This is a procedural unit separation event, no financial or operational impact announced."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":64069999.99999999,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":378029,"accession_number":"0001104659-22-058974","cik":1876716,"company_name":"ASPAC II Acquisition Corp.","ticker":"ASCBF","form_type":"8-K","filed_at":"2022-05-12T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"A SPAC II Acquisition Corp. closes IPO of 20M units at $10.00, raising $200M; trust funded with $203.5M","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["IPO of 20,000,000 units at $10.00 each generated gross proceeds of $200,000,000.","Private placement of 8,966,000 warrants at $1.00 each generated $8,966,000.","Net proceeds of $203,500,000 ($10.175 per unit) deposited in trust account.","Transaction costs totaled $13,150,218 including underwriting, deferred fees, and representative shares.","Company has 15 months (possible 21-month extension) to complete initial business combination."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":64069999.99999999,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":378028,"accession_number":"0001104659-22-056929","cik":1876716,"company_name":"ASPAC II Acquisition Corp.","ticker":"ASCBF","form_type":"8-K","filed_at":"2022-05-06T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"SPAC II Acquisition Corp. closes IPO of 20M units, raises $200M gross; private placement adds $8.97M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["IPO of 20,000,000 units at $10.00/unit for gross proceeds of $200,000,000.","Simultaneous private placement of 8,966,000 warrants at $1.00 each to sponsor, raising $8,966,000.","Total of $203,500,000 deposited into trust account for benefit of public shareholders.","Each unit consists of one Class A ordinary share, one-half redeemable warrant, and one right."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":64069999.99999999,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}